In-vitro lung model for drug testing
AlveoliX AG
Incorporated
14.07.2015Headquarters
BernSupport
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.
News
Promising Swiss innovations unveiled at VivaTech 2025 (startupticker.ch)
AlveoliX and AMYRA report breakthroughs (startupticker.ch)
EU funds AI-driven medical projects powered by Swiss startups (startupticker.ch)
European consortiums with Swiss startups awarded grants (startupticker.ch)
"Innovation is a people’s business" — Interview with Sebastien Hug of the Innovation Office at UNIBE (venturelab.swiss)
Alveolix gewinnt Swiss Medtech Award (startupticker.ch)
Three startups contest for the Swiss Medtech Award (startupticker.ch)
Thirteen Swiss startups receive Eurostars grants (startupticker.ch)
Milestones news
First customer for our lung-on-chip :-)
Documents
Videos and Presentations
Swiss Medtech Award Lung on Chip